CClinicalTrials.gg
Sign In
RecruitingNCT06638073Updated Mar 12, 2026

Continuous Connected Patient Care (CCPC), a Pilot Testing a Novel Device for Continuous Vitals Monitoring - Department of Anesthesia at PHC

An observational study in Surgical Procedure, Unspecified and Intensive Care Units (ICUs), sponsored by Medtronic - MITG. Recruiting at 1 site in Canada. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2026-03-12.

Sponsored by Medtronic - MITG · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
50
Ages
19 Years and older
Sex
All
01

Study summary

To confirm feasibility and accessibility of the CCPC Platform (Oxymotion, Bridge Health Solutions medication adherence software, CloudDX home kit) in two different environments - in hospital and at-home, in patients undergoing non-cardiac surgery.

02

Conditions studied

  • Surgical Procedure, Unspecified
  • Intensive Care Units (ICUs)
03

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients that have undergone a non-cardiac surgery requiring an inpatient hospital stay and peri-op patients who are in the Surgical High Acuity Unit (SHAU) at SPH.

Inclusion criteria

  • 19 years or older
  • Patients that have undergone a non-cardiac surgery at SPH requiring an inpatient hospital stay
  • Peri-op patients who are in the Surgical High Acuity Unit (SHAU) and those followed by Anesthesia Perioperative Outreach team on the ward
  • Living within British Columbia, Canada and in an area that is covered by Bell cellular network

Exclusion criteria

Exclusion Criteria:

  • Patient refusal
  • Lack of capacity to consent to the study (including having received sedative or general anesthetic within the past 24 hours)
  • Unable to use (or does not have a caregiver who can help put on) study monitoring device at home
  • Unable to complete (or does not have a caregiver who can help complete) study questionnaires by electronic (mobile, tablet, or computer), paper, nor phone
  • No access to cell phone nor landline at home to receive follow-ups
  • Preoperatively known to be discharged to a nursing home or rehabilitation facility
  • Known allergic reactions to any part material of study devices
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
50 participants (estimated)
Patient registry
No
05

What researchers measure

Primary outcomes

  1. Collect patient and clinicians' feedback about the CCPC Platform

    This will be completed via an assessment of the quantitative data on how long and how often patients use this monitoring and what were the reasons that patients took the monitors on and off.

    Time frame: From enrollment to the end of follow up at 10 days

  2. Confirm the technical goals of the CCPC platform are met.

    This will be completed by ensuring clinical workflow is met when using the monitoring platform.

    Time frame: From enrollment to the end of follow up at 10 days

  3. Collect patient and clinicians' feedback about the CCPC Platform

    This will be completed via an assessment of the Usability questionnaires.

    Time frame: From enrollment to the end of follow up at 10 days

  4. Collect patient and clinicians' feedback about the CCPC Platform

    This will be completed by an evaluation of potential harm, adverse events and safety issues.

    Time frame: From enrollment to the end of follow up at 10 days

  5. Confirm the technical goals of the CCPC platform are met.

    This will be completed via an assessment of the data flow: does the correct patient vitals information reach the clinicians at the right time?

    Time frame: From enrollment to the end of follow up at 10 days

  6. Confirm the technical goals of the CCPC platform are met.

    This will be completed by determining if the CCPC platform provided a holistic view of each patient with vitals, medication, and other collected data.

    Time frame: From enrollment to the end of follow up at 10 days

06

Study locations

1 of 1 sites recruiting
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT06638073
Lead sponsor
Medtronic - MITG
Collaborators
Excelar, Cloud DX Inc., Bridge Health Solutions, Providence Healthcare
Responsible party
Sponsor
First posted
Oct 15, 2024
Start date
Mar 13, 2025
Primary completion
Jun 20, 2026 (estimated)
Completion
Jun 20, 2026 (estimated)
Last update
Mar 12, 2026

Study contacts

Elise Huisman
Contact
elise.huisman@medtronic.com
+1 236-308-4876

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Medtronic - MITG

Start the discussion